Skip to content
Sustainable aviation fuel (SAF) uses the power of biology to launch airliners. A group of senators said they will use their legislative power to […]
Senate Sustainable Aviation Caucus to back pro-SAF legislation Read More »
Sen. Todd Young (R-IN) was recently named Chair of the National Security Commission on Emerging Biotechnology (NSCEB), established by Congress to recommend policy on biotech and national security.
A new suite of rules governing drug rebates in Medicaid has been finalized, removing months of uncertainty about whether the Centers for Medicare and
September is Sepsis Awareness Month, and the Biotechnology Innovation Organization (BIO) is partnering with Sepsis Alliance to spread the word about sepsis and provide
Sepsis Awareness Month: 3 things you need to know about sepsis Read More »
American leadership in biotechnology is a vital national security asset in need of protection now, and its importance can be expected to grow in
I am BIO Podcast: Biotechnology is national security technology Read More »
Since 2019, the Biotechnology Innovation Organization (BIO) has worked with BBC StoryWorks Commercial Productions, the BBC’s award-winning branded content division, to bring stories of
BIO and BBC StoryWorks call for biotech stories Read More »
During a busy week in Congress, House legislation to support drug development for pediatric rare diseases moved forward with bipartisan support, and a Senate
Capitol Hill update: House advances PPRV reauthorization, Senate reviews IRA Read More »
Virginia Gov. Glenn Youngkin on Sept. 17 received the 2024 Governor of the Year Award from the Biotechnology Innovation Organization (BIO) in recognition of
Virginia Gov. Youngkin named BIO’s Governor of the Year Read More »
John Torres, Senior Director, Federal Government Relations – Agriculture and Environment at the Biotechnology Innovation Organization (BIO), was recently appointed to the U.S. Department
BIO’s John Torres on his appointment to the ATAC and the future of agricultural trade Read More »
Yesterday, Sen. Bernie Sanders held a meeting about the new class of groundbreaking diabetes and weight-loss medicines. Next week, he will hold a hearing
